Results 351 to 360 of about 225,804 (391)
Some of the next articles are maybe not open access.
Placenta-derived microparticles
Thrombosis Research, 2013Microparticles (MPs), sub-micron membrane vesicles, participate in the placental and maternal crosstalk in normal pregnancies as well as in gestational vascular complications (GVC). The article will review the effects of MPs on placental physiological processes, including hemostasis, trophoblast migration, invasion, placental vasculature and their ...
Anat, Aharon, Benjamin, Brenner
openaire +2 more sources
Pathophysiology of Haemostasis and Thrombosis, 2007
Cancer is a prothrombotic state, with an increased prevalence of arterial and venous thromboemboli. Microparticles (MPs) are sub-micron-sized vesicles derived from activated or apoptotic cancer cells and/or host cells that may causally contribute to these clinical events, although the strength of the evidence thus far is inconclusive.
Chirag, Amin +2 more
openaire +2 more sources
Cancer is a prothrombotic state, with an increased prevalence of arterial and venous thromboemboli. Microparticles (MPs) are sub-micron-sized vesicles derived from activated or apoptotic cancer cells and/or host cells that may causally contribute to these clinical events, although the strength of the evidence thus far is inconclusive.
Chirag, Amin +2 more
openaire +2 more sources
Slow-release melarsoprol microparticles
International Journal of Pharmaceutics, 2002The present study compares two methods of preparation of microparticles of melarsoprol for the treatment of the human trypanosomiasis. Melarsoprol is poorly soluble in water and in organic media. Microparticles were formulated with modified O/W and W/O/W methods, Poly(epsilon -caprolactone) microparticles were prepared either with a suspension-in-oil ...
Gibaud, Stéphane +2 more
openaire +3 more sources
Designable Polymeric Microparticles from Droplet Microfluidics for Controlled Drug Release
Advanced Materials & Technologies, 2019Drug delivery systems that can control drug release profile to ensure a high therapeutic efficacy and reduced side effects are highly desired in pharmaceutical and biomedical fields.
Fangfang He +9 more
semanticscholar +1 more source
Microparticles and infectious diseases
Médecine et Maladies Infectieuses, 2012Membrane shedding with microvesicle (MV) release after membrane budding due to cell stimulation is a highly conserved intercellular interplay. MV can be released by micro-organisms or by host cells in the course of infectious diseases. Host MVs are divided according to cell compartment origin in microparticles (MPs) from plasma membrane and exosomes ...
X, Delabranche +3 more
openaire +2 more sources
Microparticles and Arterial Disease
Seminars in Thrombosis and Hemostasis, 2009Microparticles (MPs) are small (diameter
Andrew, Blann +2 more
openaire +2 more sources
Journal of Applied Physics, 1962
Using a simple model, the motion of an ensemble of small conducting spheres located between two parallel electrodes is investigated theoretically in the case where the flow is space-charge-limited. A more realistic but more complicated model is proposed.
Ch. Maisonnier, M. Haegi
openaire +1 more source
Using a simple model, the motion of an ensemble of small conducting spheres located between two parallel electrodes is investigated theoretically in the case where the flow is space-charge-limited. A more realistic but more complicated model is proposed.
Ch. Maisonnier, M. Haegi
openaire +1 more source
Microparticles with neuroactive agents
Journal of Microencapsulation, 1995An overview of biodegradable and biocompatible microcapsules and microspheres loaded with neuroactive substances, or cells producing neuroactive substances, and their role as drug delivery systems (DDS) for drug administration to the central nervous system (CNS) is given. In addition, closely related systems are also summarized.
Filipović-Grčić, Jelena +2 more
openaire +4 more sources
Endothelial microparticles in diseases
Cell and Tissue Research, 2008Microparticles are submicron vesicles shed from plasma membranes in response to cell activation, injury, and/or apoptosis. The measurement of the phospholipid content (mainly phosphatidylserine; PSer) of microparticles and the detection of proteins specific for the cells from which they are derived has allowed their quantification and characterization.
Gilles N, Chironi +5 more
openaire +2 more sources
Microparticles and thrombotic disease
Current Opinion in Hematology, 2009In recent years, the biological importance of cell-derived microparticles has emerged. However, even without standard protocols for their analysis, the role of microparticles in hemostasis and thrombosis is evident, particularly in cancer patients.When found in the blood in high numbers, microparticles are prothrombotic.
Pavel, Davizon, José A, López
openaire +2 more sources